Trial Profile

A prospective, single centre study to assess changes in the ocular surface status and intraocular pressure lowering effects of patients with primary open‐angle glaucoma (POAG) or ocular hypertension (OH), and the presence of existing prostaglandin‐induced corneal disorders after being switched from latanoprost 0.005% to tafluprost 0.0015% ophthalmic solution

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 19 Sep 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com